# Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration

> **NCT07725900** · PHASE2,PHASE3 · COMPLETED · sponsor: **Naniek Widyaningrum** · enrollment: 300 (actual)

## Conditions studied

- Hyperpigmentation
- Dry Skin
- Erythema

## Interventions

- **OTHER:** MB Luxury Skincare containing Epigallocatechin Gallate (EGCG)

## Key facts

- **NCT ID:** NCT07725900
- **Lead sponsor:** Naniek Widyaningrum
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725900, "Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*